DAIHAN Scientific Co., Ltd.

KOSDAQ:A131220 Stock Report

Market Cap: ₩27.9b

DAIHAN Scientific Balance Sheet Health

Financial Health criteria checks 5/6

DAIHAN Scientific has a total shareholder equity of ₩56.6B and total debt of ₩433.7M, which brings its debt-to-equity ratio to 0.8%. Its total assets and total liabilities are ₩71.0B and ₩14.4B respectively. DAIHAN Scientific's EBIT is ₩5.6B making its interest coverage ratio -20.5. It has cash and short-term investments of ₩16.2B.

Key information

0.77%

Debt to equity ratio

₩433.71m

Debt

Interest coverage ratio-20.5x
Cash₩16.19b
Equity₩56.55b
Total liabilities₩14.45b
Total assets₩71.00b

Recent financial health updates

No updates

Recent updates

Analysis Article Nov 09

DAIHAN Scientific (KOSDAQ:131220) Is Paying Out A Dividend Of ₩60.00

The board of DAIHAN Scientific Co., Ltd. ( KOSDAQ:131220 ) has announced that it will pay a dividend on the 13th of...
Analysis Article Aug 27

Shareholders Can Be Confident That DAIHAN Scientific's (KOSDAQ:131220) Earnings Are High Quality

Even though DAIHAN Scientific Co., Ltd.'s ( KOSDAQ:131220 ) recent earnings release was robust, the market didn't seem...
Analysis Article Apr 21

Optimistic Investors Push DAIHAN Scientific Co., Ltd. (KOSDAQ:131220) Shares Up 29% But Growth Is Lacking

The DAIHAN Scientific Co., Ltd. ( KOSDAQ:131220 ) share price has done very well over the last month, posting an...
Analysis Article Apr 12

Does DAIHAN Scientific (KOSDAQ:131220) Deserve A Spot On Your Watchlist?

Like a puppy chasing its tail, some new investors often chase 'the next big thing', even if that means buying 'story...
Analysis Article Mar 29

A Look At The Fair Value Of DAIHAN Scientific Co., Ltd. (KOSDAQ:131220)

Does the March share price for DAIHAN Scientific Co., Ltd. ( KOSDAQ:131220 ) reflect what it's really worth? Today, we...
Analysis Article Mar 11

The DAIHAN Scientific (KOSDAQ:131220) Share Price Has Gained 173%, So Why Not Pay It Some Attention?

The last three months have been tough on DAIHAN Scientific Co., Ltd. ( KOSDAQ:131220 ) shareholders, who have seen the...
Analysis Article Feb 18

Shareholders Are Loving DAIHAN Scientific Co., Ltd.'s (KOSDAQ:131220) 0.4% Yield

Could DAIHAN Scientific Co., Ltd. ( KOSDAQ:131220 ) be an attractive dividend share to own for the long haul? Investors...
Analysis Article Jan 24

We Like These Underlying Trends At DAIHAN Scientific (KOSDAQ:131220)

What are the early trends we should look for to identify a stock that could multiply in value over the long term...
Analysis Article Dec 27

What Type Of Shareholders Own The Most Number of DAIHAN Scientific Co., Ltd. (KOSDAQ:131220) Shares?

Every investor in DAIHAN Scientific Co., Ltd. ( KOSDAQ:131220 ) should be aware of the most powerful shareholder...
Analysis Article Nov 30

DAIHAN Scientific Co., Ltd.'s (KOSDAQ:131220) Stock Is Going Strong: Is the Market Following Fundamentals?

DAIHAN Scientific (KOSDAQ:131220) has had a great run on the share market with its stock up by a significant 206% over...
Analysis Article Jul 14

Is DAIHAN Scientific Co., Ltd. (KOSDAQ:131220) A Good Fit For Your Dividend Portfolio?

Today we'll take a closer look at DAIHAN Scientific Co., Ltd. (KOSDAQ:131220) from a dividend investor's perspective...

Financial Position Analysis

Short Term Liabilities: A131220's short term assets (₩51.4B) exceed its short term liabilities (₩13.2B).

Long Term Liabilities: A131220's short term assets (₩51.4B) exceed its long term liabilities (₩1.2B).


Debt to Equity History and Analysis

Debt Level: A131220 has more cash than its total debt.

Reducing Debt: A131220's debt to equity ratio has increased from 0.2% to 0.8% over the past 5 years.

Debt Coverage: A131220's debt is well covered by operating cash flow (1560%).

Interest Coverage: A131220 earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/27 22:26
End of Day Share Price 2026/07/27 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

DAIHAN Scientific Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.